Mary Butlevics is a pharmacist who is specialized in Geriatric in Ada, Michigan. Patients can reach her at 3035 Torian Ct Se, Ada or contact her on 616-920-4474. Active license number of Mary Butlevics is 5302027548 for Geriatric in Michigan. Mary Butlevics is a pharmacist who is certified in geriatric pharmacy practice is designated as a “Certified Geriatric Pharmacist” (CGP). To become certified, candidates are expected to be knowledgeable about principles of geriatric pharmacotherapy and the provision of pharmaceutical care to the elderly.
Complete Profile:
Mary Butlevics speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
Name:
Mary Butlevics
Specialization:
Geriatric
Credentials:
PHARMD
Gender:
Female
Location:
3035 Torian Ct Se, Ada, Michigan, 49301-8335
Phone:
616-920-4474
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mary Butlevics are as mentioned below.
NPI Number:
1578140141
NPI Enumeration Date:
28 Mar, 2021
NPI Last Update On:
28 Mar, 2021
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mary Butlevics are as mentioned below.
Specialization
License Number
State
Status
Geriatric
5302027548
Michigan
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3035 Torian Ct Se, Ada, Michigan
Zip:
49301-8335
Phone Number:
616-920-4474
Fax Number:
--
Patients can reach Mary Butlevics at 3035 Torian Ct Se, Ada, Michigan or can call on phone at 616-920-4474.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.